These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 1913190)

  • 1. Potentiation of angiotensin II-induced drinking by glucocorticoids is a specific glucocorticoid type II receptor (GR)-mediated event.
    Sumners C; Gault TR; Fregly MJ
    Brain Res; 1991 Jun; 552(2):283-90. PubMed ID: 1913190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoids potentiate the dipsogenic action of angiotensin II.
    Ganesan R; Sumners C
    Brain Res; 1989 Oct; 499(1):121-30. PubMed ID: 2804659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a nonpeptide angiotensin II receptor antagonist, DuP 753, on angiotensin-related water intake in rats.
    Fregly MJ; Rowland NE
    Brain Res Bull; 1991 Jul; 27(1):97-100. PubMed ID: 1933441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mineralocorticoids modulate central angiotensin II receptors in rats.
    Wilson KM; Sumners C; Hathaway S; Fregly MJ
    Brain Res; 1986 Sep; 382(1):87-96. PubMed ID: 3768684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the role of brain mineralocorticoid (type I) and glucocorticoid (type II) receptors in neuroendocrine regulation.
    Ratka A; Sutanto W; Bloemers M; de Kloet ER
    Neuroendocrinology; 1989 Aug; 50(2):117-23. PubMed ID: 2550833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid and mineralocorticoid receptors are involved in the facilitation of anxiety-like response induced by restraint.
    Calvo N; Volosin M
    Neuroendocrinology; 2001 Apr; 73(4):261-71. PubMed ID: 11340340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular and dipsogenic effects of angiotensin II administered i.c.v. in Long-Evans and Brattleboro rats.
    Harland D; Gardiner SM; Bennett T
    Brain Res; 1988 Jul; 455(1):58-64. PubMed ID: 3416193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of glucocorticoids in the regulation of brain prostaglandin biosynthesis under basal conditions and in response to endotoxin.
    Weidenfeld J; Amir I; Shohami E
    Endocrinology; 1993 Mar; 132(3):941-5. PubMed ID: 8440197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a non-peptide angiotensin receptor antagonist on drinking and blood pressure responses to centrally administered angiotensins in the rat.
    Kirby RF; Thunhorst RL; Johnson AK
    Brain Res; 1992 Apr; 576(2):348-50. PubMed ID: 1515929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of atrial natriuretic factor on central angiotensin II-induced responses in rats.
    Nakamaru M; Takayanagi R; Inagami T
    Peptides; 1986; 7(2):373-5. PubMed ID: 2942846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of subfornical organ lesions and ventricular blockade on drinking induced by angiotensin II.
    Hoffman WE; Phillips MI
    Brain Res; 1976 May; 108(1):59-73. PubMed ID: 1276893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothalamic alpha-adrenergic blockade modifies drinking and blood pressure responses to central angiotensin II in conscious rats.
    Jones DL
    Can J Physiol Pharmacol; 1988 Oct; 66(10):1270-7. PubMed ID: 2907299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of angiotensin, AT1 and AT2 receptors in the pressor, drinking and vasopressin responses to central angiotensin.
    Hogarty DC; Speakman EA; Puig V; Phillips MI
    Brain Res; 1992 Jul; 586(2):289-94. PubMed ID: 1521162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential central effects of mineralocorticoid and glucocorticoid agonists and antagonists on blood pressure.
    van den Berg DT; de Kloet ER; van Dijken HH; de Jong W
    Endocrinology; 1990 Jan; 126(1):118-24. PubMed ID: 2293978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amastatin potentiation of drinking induced by blood-borne angiotensin: evidence for mediation by endogenous brain angiotensin.
    Sullivan MJ; Beltz TG; Johnson AK
    Brain Res; 1990 Mar; 510(2):237-41. PubMed ID: 2331601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of endogenous opioid peptides in central glucocorticoid receptor (GR)-induced decreases in circulating LH in the male rat.
    Briski KP; Vogel KL
    Neuropeptides; 1995 Mar; 28(3):175-81. PubMed ID: 7791961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the alpha 1- and alpha 2-adrenoceptors of the lateral hypothalamus in the dipsogenic response to central angiotensin II in rats.
    Ferrari AC; Camargo LA; Saad WA; Renzi A; Luca Júnior LA; Menani JV
    Brain Res; 1991 Sep; 560(1-2):291-6. PubMed ID: 1684731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of aminopeptidase inhibitors on brain angiotensin metabolism and drinking in rats.
    Wright JW; Quirk WS; Hanesworth JM; Harding JW
    Brain Res; 1988 Feb; 441(1-2):215-20. PubMed ID: 3359232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonism of type II, but not type I glucocorticoid receptors results in elevated basal luteinizing hormone release in male rats.
    Briski KP; Sylvester PW
    Neuroendocrinology; 1994 Dec; 60(6):601-8. PubMed ID: 7700503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of angiotensin II binding sites in neuronal cultures by mineralocorticoids.
    Sumners C; Fregly MJ
    Am J Physiol; 1989 Jan; 256(1 Pt 1):C121-9. PubMed ID: 2912130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.